Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changlin Mei

Showing results (121-130 of 181) with videos related to

Pageof 19
Sort By:
Investigational New Drugs|September 17, 2009
DH9, a novel PPARγ agonist suppresses the proliferation of ADPKD epithelial cells: An association with an inhibition of β-catenin signalingMoyan Liu, Lili Fu, Chunyan Liu, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 9, 2013
Urinary interleukin 18 for detection of acute kidney injury: a meta-analysisYawei Liu, Wenyuan Guo, Jiayou Zhang, et al.
Investigational New Drugs|January 14, 2009
B5, a novel pyrrole-substituted indolinone, exerts potent antitumor efficacy through G2/M cell cycle arrestXishan Xiong, Yingwei Zhang, Xiang Gao, et al.
Journal of Cellular and Molecular Medicine|September 22, 2021
NS398 as a potential drug for autosomal-dominant polycystic kidney disease: Analysis using bioinformatics, and zebrafish and mouse modelsSixiu Chen, Linxi Huang, Shoulian Zhou, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 26, 2022
Susceptibility of renal fibrosis in diabetes: Role of hypoxia inducible factor-1Shuqin Mei, Lin Li, Xiangjun Zhou, et al.
Clinical and Experimental Nephrology|January 11, 2014
Idiopathic nodular glomerulosclerosis in Chinese patients: a clinicopathologic study of 20 casesJun Wu, Shengqiang Yu, Vickram Tejwani, et al.
World Journal of Urology|February 18, 2009
Comparison of unilateral renal artery embolization versus bilateral for treatment of severe refractory hypertension in hemodialysis patientsZhiguo Mao, Chaoyang Ye, Changlin Mei, et al.
Investigational New Drugs|August 16, 2008
Antitumor activity of a novel series of alpha-aryloxy-alpha-methylhydrocinnamic acid derivatives as PPAR gamma agonists against a panel of human cancer cell linesXishan Xiong, Yangliang Ye, Lili Fu, et al.
Clinical Kidney Journal|June 7, 2021
Efficacy and safety of rituximab in adult frequent-relapsing or steroid-dependent minimal change disease or focal segmental glomerulosclerosis: a systematic review and meta-analysisCheng Xue, Bo Yang, Jing Xu, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|July 6, 2026
A platelet-monocyte pyroptotic axis mediates uremic cardiomyopathy: critical role of PF4 and hematopoietic caspase-1Yang Yang, Minyu Zhang, Meihan Chen, et al.
Pageof 19

Showing results (121-130 of 181) with videos related to

Sort By:
Pageof 19
Investigational New Drugs|September 17, 2009
DH9, a novel PPARγ agonist suppresses the proliferation of ADPKD epithelial cells: An association with an inhibition of β-catenin signalingMoyan Liu, Lili Fu, Chunyan Liu, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 9, 2013
Urinary interleukin 18 for detection of acute kidney injury: a meta-analysisYawei Liu, Wenyuan Guo, Jiayou Zhang, et al.
Investigational New Drugs|January 14, 2009
B5, a novel pyrrole-substituted indolinone, exerts potent antitumor efficacy through G2/M cell cycle arrestXishan Xiong, Yingwei Zhang, Xiang Gao, et al.
Journal of Cellular and Molecular Medicine|September 22, 2021
NS398 as a potential drug for autosomal-dominant polycystic kidney disease: Analysis using bioinformatics, and zebrafish and mouse modelsSixiu Chen, Linxi Huang, Shoulian Zhou, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 26, 2022
Susceptibility of renal fibrosis in diabetes: Role of hypoxia inducible factor-1Shuqin Mei, Lin Li, Xiangjun Zhou, et al.
Clinical and Experimental Nephrology|January 11, 2014
Idiopathic nodular glomerulosclerosis in Chinese patients: a clinicopathologic study of 20 casesJun Wu, Shengqiang Yu, Vickram Tejwani, et al.
World Journal of Urology|February 18, 2009
Comparison of unilateral renal artery embolization versus bilateral for treatment of severe refractory hypertension in hemodialysis patientsZhiguo Mao, Chaoyang Ye, Changlin Mei, et al.
Investigational New Drugs|August 16, 2008
Antitumor activity of a novel series of alpha-aryloxy-alpha-methylhydrocinnamic acid derivatives as PPAR gamma agonists against a panel of human cancer cell linesXishan Xiong, Yangliang Ye, Lili Fu, et al.
Clinical Kidney Journal|June 7, 2021
Efficacy and safety of rituximab in adult frequent-relapsing or steroid-dependent minimal change disease or focal segmental glomerulosclerosis: a systematic review and meta-analysisCheng Xue, Bo Yang, Jing Xu, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|July 6, 2026
A platelet-monocyte pyroptotic axis mediates uremic cardiomyopathy: critical role of PF4 and hematopoietic caspase-1Yang Yang, Minyu Zhang, Meihan Chen, et al.
Pageof 19